Cambridge New Therapeutics Forum (CamNTF): May Event

This meeting will be hosted by the Alzheimer’s Research UK Cambridge Drug Discovery Institute & Cambridge UK Dementia Research Institute


17:30 – Arrival, Registration, Tea & Coffee

18:00 – Welcome

18:10 – Prof David Rubinsztein, FMedSci FRS, CIMR Deputy Director, Professor of Molecular Neurogenetics, Wellcome Trust Principal Research Fellow, Honorary Consultant in Medical Genetics
Autophagy, a guardian against neurodegeneration

18:25 – Dr Rebecca Taylor, Research Leader, MRC LMB
Investigating the Neuronal Roles of XBP1

18:40 – Dr Mark Halliday, MRC Toxicology Unit, Career Development Fellow
Repurposing drugs to treat neurodegeneration

19:10 – Networking and Refreshments

20:00 – Meeting close